CRLF2 and acute lymphoblastic leukemia: While the PTPN11-inhibitor reduced wtRAS activity in MUTZ5- cells (Fig. 3c), the connection between PTPN11 and RAS in ALL as well as in CRLF2-signaling is unknown.